Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Interest in the therapeutic applications of peptides is surging. Their specificity, potency, and low toxicity make these molecules valuable for treating conditions such as metabolic disorders, cancer, and autoimmune diseases. However, a significant challenge remains—achieving effective oral delivery. Traditionally, peptides have been administered by injection due to poor bioavailability, but there is growing interest in overcoming these barriers to enable oral administration, which could improve patient compliance and expand therapeutic applications.
This webinar explores the key challenges of oral peptide delivery, along with innovative solutions and future opportunities in pharmaceutical development. Attendees will gain insights into the latest research, emerging technologies, and regulatory considerations, providing a comprehensive understanding of both the scientific and practical aspects of developing oral peptide therapies. Led by Anil Kane, Ph.D., MBA, global head of technical and scientific affairs at Thermo Fisher Scientific, this on-demand webinar offers valuable insights into the following areas: